Therapy Areas: Central Nervous System
16 November 2017 - DalCor Pharmaceuticals, a company developing precision treatments by genetically targeting patients that will derive clinical benefits, has named Dr Fouzia Laghrissi-Thode as its di...
16 November 2017 - Precision treatments company DalCor Pharmaceuticals revealed on Wednesday the addition of Fouzia Laghrissi-Thode to its board of directors.Currently, Dr Laghrissi-Thode serves as vi...
13 November 2017 - Sanofi, a France-based multinational pharmaceutical company, has agreed to produce Principia Biopharma's Bruton's tyrosine kinase inhibitor, PRN2246, it was reported on Fr...
10 November 2017 - - Irish biopharmaceutical company Alkermes is calling for a formal review by the US National Institutes of Health of data related to all FDA-approved medication-assisted treatment o...
10 November 2017 - - Cambridge, Massachusetts-based CNS-focused biopharmaceutical company Sage Therapeutics, Inc. (NASDAQ: SAGE) has released positive top-line results from two Phase 3 clinical t...
10 November 2017 - - Deerfield, Illinois-based marketing and sales organization Takeda Pharmaceuticals, USA, Inc. has released GEMINI I post-hoc data evaluating deep remission with Entyvio (vedolizuma...